Table 4.

Positive high-risk human papillomavirus results and follow-up results

Randomised group	Screening history	Age Range	HPV self-sample result (type(s) detected)	Cytology follow-up result	Colposcopy follow-up result
Clinic	Never	30-39	16	Unsatisfactory	LSIL
Clinic	Under	40-49	16	ASC-US	LSIL
Home	Under	30-39	18 & Other	Atypical Cells/HSIL/CIN2/3	HSIL/AIS
Home	Under	30-39	18 & Other	Negative	LSIL
Home	Under	50-59	Other	Negative	N/A
Home	Never	40-49	Other	Negative	N/A
Home	Never	30-39	Other	Negative	N/A
Clinic	Never	40-49	Other	Negative	N/A
Home	Never	30-39	Other	Negative	N/A
Home	Under	30-39	Other	Negative	N/A
Home	Never	30-39	Other	Negative	N/A
Home	Never	40-49	Other	Negative	N/A
Clinic	Never	40-49	Other	Negative	N/A
Home	Never	40-49	Other	Negative	N/A
Home	Never	50-59	Other	Negative	N/A
Home	Under	60-69	Other	ASC-US	N/A
Home	Never	30-39	Other	ASC-US	N/A
Home	Under	30-39	Other	LSIL/CIN1/HPV	Negative
Home	Never	30-39	Other	LSIL/CIN1/HPV	Negative
Clinic	Under	30-39	Other	LSIL/CIN1/HPV	Immature squamous metaplasia
Clinic	Under	40-49	Other	HSIL suspicious for invasion	HSIL
Home	Never	30-39	Other	Atypical Cells/HSIL/CIN2/3	HSIL/CIN3
Clinic	Never	50-59	Other	Not completed	Declined follow-up
Clinic	Under	40-49	Other	Not completed	Lost to follow-up

HPV: human papillomavirus; never: never screened; LSIL: low-grade squamous intraepithelial lesion; Under: under-screened; ASC-US: atypical squamous cells of undetermined significance; HSIL: high-grade squamous intraepithelial lesion; CIN2/3: cervical intraepithelial neoplasia 2 or 3; AIS: adenocarcinoma in situ; N/A: not applicable: CIN1: cervical intraepithelial neoplasia 1.